INTERMACS Data Shows Progress Using MCS Devices in Destination Therapy as a ... MarketWatch (press release) PRAGUE, Czech Republic, Apr 18, 2012 (GlobeNewswire via COMTEX) -- Today researchers will report initial findings of a post-FDA-approval study using Left Ventricular Assist Devices as destination therapy for heart failure patients. |
